Financials

  • Market Capitalization 2.04 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.3
ratio cours/chiffre d'affaires
162.41

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1975
ADMA
ADMA Biologics Inc - Common Stock
9.34 USD-1.48%-4.69%+9.62%-45.35%2.09 B USD
1994
STOK
Stoke Therapeutics, Inc. - Common Stock
31.62 USD-2.98%-2.07%+8.10%+59.78%2.04 B USD
2006
ZYME
Zymeworks Inc. - Common Stock
28.27 USD-2.55%-1.40%+28.38%+59.36%2.01 B USD
2007
NBTX
Nanobiotix S.A. - ADSs
41.23 USD-8.70%+1.25%+7.88%+397.35%2.00 B USD